Interactive Tool
Model the system-level financial impact of deploying RedCap across your prescription volume. Based on the Congressional Budget Office's medical offset methodology and 2024 National Health Expenditure data.
Methodology: Each 1% relative increase in prescriptions filled is estimated to reduce spending on other medical services by ~0.2% (CBO Medicare offset, extrapolated all-payer using 2024 NHE of $4.8T excluding Rx). Scenarios are deliberately conservative relative to peer-reviewed reminder-packaging study effects.
Quick Scenarios
In increments of 250M up to 2B annual prescriptions
This tool is for illustrative purposes only. Results are based on published CBO methodology and 2024 NHE data. Actual outcomes will vary by formulary, patient population, and implementation.
Net Annual System-Level Savings
$56.5B
ROI of 5136% on total deployment cost of $1.1B
30M
Additional prescriptions filled annually due to the 6.0% adherence lift across 500M annual Rx
$1.1B
Dispensing fee ($0.5B) + cost of incremental fills ($0.6B)
$57.6B
1.20% reduction in $4.8T non-Rx medical spend via CBO offset
51.4×
Every $1 invested in RedCap deployment returns $52.36 in system-level savings
Savings vs. Cost Breakdown
Every number in this estimator is traceable to a published source. Expand any section below for a full explanation.